Germline RBBP8 variants associated with early-onset breast cancer compromise replication fork stability

J Clin Invest. 2020 Aug 3;130(8):4069-4080. doi: 10.1172/JCI127521.

Abstract

Haploinsufficiency of factors governing genome stability underlies hereditary breast and ovarian cancer. One significant pathway that is disabled as a result is homologous recombination repair (HRR). With the aim of identifying new candidate genes, we examined early-onset breast cancer patients negative for BRCA1 and BRCA2 pathogenic variants. Here, we focused on CtIP (RBBP8 gene), which mediates HRR through the end resection of DNA double-strand breaks (DSBs). Notably, these patients exhibited a number of rare germline RBBP8 variants. Functional analysis revealed that these variants did not affect DNA DSB end resection efficiency. However, expression of a subset of variants led to deleterious nucleolytic degradation of stalled DNA replication forks in a manner similar to that of cells lacking BRCA1 or BRCA2. In contrast to BRCA1 and BRCA2, CtIP deficiency promoted the helicase-driven destabilization of RAD51 nucleofilaments at damaged DNA replication forks. Taken together, our work identifies CtIP as a critical regulator of DNA replication fork integrity, which, when compromised, may predispose to the development of early-onset breast cancer.

Keywords: Cell Biology; Genetic instability; Genetics.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Breast Neoplasms* / enzymology
  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / pathology
  • DNA Breaks, Double-Stranded
  • DNA Replication*
  • DNA, Neoplasm* / genetics
  • DNA, Neoplasm* / metabolism
  • Endodeoxyribonucleases* / genetics
  • Endodeoxyribonucleases* / metabolism
  • Female
  • Germ-Line Mutation*
  • Humans
  • MCF-7 Cells
  • Neoplasm Proteins* / genetics
  • Neoplasm Proteins* / metabolism

Substances

  • DNA, Neoplasm
  • Neoplasm Proteins
  • Endodeoxyribonucleases
  • RBBP8 protein, human